Helicobacter pylori Infection - Biotech, Pharma and Life Science Channel

07:23 EDT 31st July 2015 | BioPortfolio

PubMed Articles [6800 Associated PubMed Articles listed on BioPortfolio]

Enhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block Copolymer.

Fungal infections are an important cause of morbidity and mortality in immunocompromised patients. Amphotericin B (AMB), with broad-spectrum antifungal activity, has long been recognized as a powerful...

Control of Escherichia coli O157 on beef at 37, 22 and 4 °C by T5-, T1-, T4-and O1-like bacteriophages.

Efficacy of four bacteriophages (phages) and a cocktail for biocontrol of Escherichia coli O157 was assessed on beef samples stored at 4, 22 and 37 °C. Samples (3 × 3 × 1 cm) were contaminate...

Diagnosis and therapy of Capillaria plica infection: report and literature review.

Worldwide, data on Capillaria (Pearsonema) plica infections of the urinary tract in domestic carnivores are limited. Nevertheless, cystitis with hematuria, dysuria or pollakiuria may suggest a C. plic...

Wild boars meat as a potential source of human trichinellosis in Poland: current data.

Trichinellosis is an epidemiological problem with a global distribution. In Poland a substantial increase of the wild boar population has been observed since 2010, together with an increased incidence...

Variations in cercarial production and the level of in vitro activation of metacercariae of two different isolates of Fasciola hepatica.

Fasciola hepatica infections cause large economic losses and are a serious veterinary medicine problem in many regions of the world. Recent studies examining fascioliasis in the bison population from ...

Chimeric DNA vaccines encoding Eimeria acervulina macrophage migration inhibitory factor (E.MIF) induce partial protection against experimental Eimeria infection.

Chimeric DNA vaccines co-expressing Eimeria acervulina macrophage migration inhibitory factor (E.MIF) and chicken IL-2 (IL-2) or interferon-γ (IFN-γ) were constructed and their efficacies against E....

Comparison of pathogens infection level in Ips typographus (Coleoptera: Curculionidae) beetles sampled in pheromone traps and at place of overwintering.

The importance of pathogens in the population dynamics of Ips typographus remains a subject of ongoing debate. The main objective of our experiment was to compare the pathogen infection levels of indi...

Trypanosoma cruzi DTU TcII presents higher blood parasitism than DTU TcI in an experimental model of mixed infection.

Trypanosoma cruzi (Tc), the causative agent of Chagas disease, affects millions of people worldwide. One of the major characteristics of T. cruzi is related to its heterogeneity due to the variability...

Eye fluke infection status in Baltic cod, Gadus morhua, after three decades and their use as ecological indicators.

Eye flukes of the genus Diplostomum were recorded with a prevalence of 7.4% and a mean intensity of 11.9 (range 1-75) parasites per fish in eye lenses of a total of 188 Atlantic cod, Gadus morhua, sam...

Ophthalmology hospital wards contamination to pathogenic free living Amoebae in Iran.

The present study was conducted to determine the occurrence of potentially pathogenic free-living amoeba in ophthalmology wards in reference hospitals in Iran. Since an increasing number of Acanthamoe...

News Articles [1912 Associated News Articles listed on BioPortfolio]

AmpliPhi to Present Research on Efficacy of a Novel Bacteriophage Cocktail in S. aureus Lung Infection Model at ICAAC/ICC 2015.

San Diego and Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, July 30, 2015 – AmpliPhi BioSciences Corporation (OTCQB: APHB), a global leader in the development of bacteriophage...

PNAS Paper Details Efficacy of a Potent, Fully Human Antibody for the Treatment of MERS

Humabs BioMed SA announced that Proceedings of the National Academy of Sciences (PNAS) has published a paper describing the isolation and characterization of a potent antibody from memory B-cells of a...

AmpliPhi to Present Research on Efficacy of a Novel Bacteriophage Cocktail in S. aureus Lung Infection Model at ICAAC/ICC 2015

AmpliPhi BioSciences Corporation (OTCQB: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, today announc...

AHF on President Obama’s Latest AIDS Plan: More Action, Less Strategy Needed

AHF lauds President for newfound focus on the Southern US, where the epidemic has been exploding, but says greater focus—and resources—should be dedicated to ‘treatment as p...

Morgan & Morgan Files Lawsuit Against 3M for Knee Implant Infection Allegedly Caused by Its Surgical Warming Blanket, the Bair Hugger

Law firm Morgan & Morgan has filed their first complaint against Arizant Healthcare, a 3M subsidiary, over its popular Bair Hugger forced-air patient warming device. The lawsuit alleges that the w...

Evolutionary War Between Microorganisms is Affecting Human Health, IU Biologist Says

Health experts have warned for years that the overuse of antibiotics is creating "superbugs" able to resist drugs treating infection. But now scientists at Indiana University and elsewhere are finding...

Persistent Severe Back Pain Could Indicate Rare Spine Infection

Patients with back pain that doesn’t go away despite therapy may have a spine infection that could lead to paralysis or death if not diagnosed and treated correctly, note the first U.S. guidelin...

In Rare Cases, Infection May Be at Root of Back Pain

THURSDAY, July 30, 2015 -- People with back pain that doesn't improve with treatment could have a rare type of spine infection, new guidelines suggest. The infection -- called vertebral osteomyelitis ...

Kicking latent HIV: New strategies to reactivate reservoirs of latent infection

In cells with latent HIV infection, the virus is dormant, and such cells are therefore not attacked by the immune system or by standard antiretroviral therapy. To eradicate the virus from the human bo...

HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article

HIV Rates in Florida Rise 23 Percent, IV Heroin Use Plays a Part in the Increase Miami, FL (PRWEB) July 30, 2015 Between 2012 and 2014 HIV infection rates rose from five to seven percent in Florida, ...

Events [0 Results]

None

Companies [60 Associated Companies listed on BioPortfolio]

MeMed Ltd.

MeMed is dedicated to improving patient lives through research, development and commercialization of pioneering products that decode the immune system's distinct responses to diff...

Ironwood Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals Co., Ltd.

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the...

FlowMetric Diagnostics Inc.

FlowMetric Diagnostics, an affiliate of FlowMetric Inc., based in Doylestown, PA and founded in December 2013, utilizes a flow cytometry-based platform to analyze cell-mediated im...

Ariste Medical, Inc.

Ariste Medical, Inc. is a privately held biotechnology company developing novel, first-in-class, drug-eluting devices to reduce infection, restenosis, and thrombosis. Located in t...

Replicor Inc.

Replicor is a privately held biopharmaceutical company with the most advanced animal and human clinical data in the development of the cure for HBV and HDV. The company is dedicat...

Clarus Linen Systems

Established in 2008, Clarus Linen Systems provides the highest quality linen services to Hospitals, Medical Clinics and Outpatient Facilities throughout the East Coast. A c...

Viamet Pharmaceuticals Inc.

Viamet is a biopharmaceutical company focused on the discovery, development and commercialization of novel antifungal agents based on its proprietary metalloenzyme medicinal chemi...

Great Basin Corporation

Great Basin Corporation is a privately held life sciences company that commercializes breakthrough multiplex chip-based technologies for the molecular, rapid diagnostic testing ma...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied fo...

CherylLeeMD® Sensitive Skin Care

CherylLeeMD® Sensitive Skin Care products are the first skin care products to work with the skin to obtain its optimal equilibrium by simultaneously addressing skin lipid defic...

Clinical Trials [1665 Associated Clinical Trials listed on BioPortfolio]

Status of Chronic Liver Disease in HCV Patients Coinfected With HIV in Andalusia

This study evaluates the current situation and follow-up of chronic HCV infection in patients co-infected with HIV in Andalusia.

Electronic Hand Hygiene Monitoring and ICU Infection Rates

If patients acquire a new infection whilst in hospital this can cause significant morbidity, prolonged hospitalisation and even death. Indeed, there is much public concern about infections...

Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection

The aim of this study was to evaluate knowledge and behavior of physicians regarding Hepatitis B Virus. The investigators designed a 30-item self-administered questionnaire assessing physi...

Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit

To investigate pharmacokinetics(PK) and pharmacodynamics(PD) of Caspofungin in ICU patients after received a loading dose of 70mg followed by 50mg (35mg if Child-Pugh score is 7-9), 40 pat...

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

This Registry will enroll adolescent and pediatric participants who received at least one Gilead Hepatitis C Virus (HCV) direct acting antiviral (DAA) while participating in a Gilead-spons...

First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C

This is a Phase 1, randomized, double-blind, placebo-controlled, first-in-human, 3-part study in which the safety, tolerability, and pharmacokinetics of orally administered AL-704 will be ...

Skin Prep to Reduce Postoperative Shoulder Infection

Propionibacterium acnes is the most common pathogen identified from a surgical site infection in the shoulder. Standard skin preps do not prevent this type of infection. Patients will und...

The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia

Dengue infection has been identified as the fastest spreading mosquito-borne viral disease by World Health Organization (WHO), which affects more than 2.5 billion people living in the subt...

Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge

Background: - Influenza is a common viral infection. But it can be deadly for some people. Researchers want to learn more about how the body fights this virus. They want to study this in ...

Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy

To determine the optimal time for the Tenofovir treatment of anti-Hepatitis B Virus (HBV) during the pregnancy among women with chronic HBV infection and high HBV DNA load. This is a rando...

Videos

None available.

Medical and Biotech [MESH] Definitions

Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).

A species of gram-negative, spiral-shaped bacteria found in the gastric mucosa that is associated with chronic antral gastritis. This bacterium was first discovered in samples removed at endoscopy from patients investigated for HELICOBACTER PYLORI colonization.

Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).

Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).


Advertisement
 
Advertisement
 
review and buy Helicobacter pylori Infection market research data and corporate reports here

Channels Quicklinks